These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2181 related items for PubMed ID: 19703124

  • 1. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A, Fernö M.
    Clin Cancer Res; 2007 Apr 01; 13(7):1987-94. PubMed ID: 17404078
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.
    Acta Oncol; 2009 Apr 01; 48(4):514-21. PubMed ID: 19107621
    [Abstract] [Full Text] [Related]

  • 4. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirström K.
    J Clin Pathol; 2008 Feb 01; 61(2):197-203. PubMed ID: 18223096
    [Abstract] [Full Text] [Related]

  • 5. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 6. Steroid hormone receptor expression in male breast cancer.
    Murphy CE, Carder PJ, Lansdown MR, Speirs V.
    Eur J Surg Oncol; 2006 Feb 01; 32(1):44-7. PubMed ID: 16260112
    [Abstract] [Full Text] [Related]

  • 7. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
    Rydén L, Landberg G, Stål O, Nordenskjöld B, Fernö M, Bendahl PO.
    Breast Cancer Res Treat; 2008 May 01; 109(2):351-7. PubMed ID: 17636399
    [Abstract] [Full Text] [Related]

  • 8. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Apr 01; 9(4):1259-66. PubMed ID: 12684393
    [Abstract] [Full Text] [Related]

  • 9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 10. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
    Hochmann J.
    Neoplasma; 2007 Jul 01; 54(4):290-6. PubMed ID: 17822318
    [Abstract] [Full Text] [Related]

  • 11. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M.
    Cancer Res; 2002 Sep 01; 62(17):4849-53. PubMed ID: 12208729
    [Abstract] [Full Text] [Related]

  • 12. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
    Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO.
    Breast Cancer Res Treat; 2010 Jan 01; 119(1):53-61. PubMed ID: 19205877
    [Abstract] [Full Text] [Related]

  • 13. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP, Perkins GH, Tucker SL, Sahin AA, Singletary SE.
    Histopathology; 2007 Jun 01; 50(7):875-80. PubMed ID: 17543077
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
    Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S.
    Cancer Chemother Pharmacol; 2003 Jul 01; 52 Suppl 1():S34-8. PubMed ID: 12819932
    [Abstract] [Full Text] [Related]

  • 15. A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.
    Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH, Murphy LC.
    Endocr Relat Cancer; 2010 Sep 01; 17(3):589-97. PubMed ID: 20418363
    [Abstract] [Full Text] [Related]

  • 16. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S.
    Eur J Cancer; 2005 Dec 01; 41(18):2924-34. PubMed ID: 16289616
    [Abstract] [Full Text] [Related]

  • 17. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
    Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K, Matsuura M, Ito Y, Akiyama F, Sakamoto G.
    J Clin Oncol; 2008 Aug 01; 26(22):3727-34. PubMed ID: 18669459
    [Abstract] [Full Text] [Related]

  • 18. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
    Koda M, Sulkowski S, Kanczuga-Koda L, Surmacz E, Sulkowska M.
    Oncol Rep; 2004 Apr 01; 11(4):753-9. PubMed ID: 15010868
    [Abstract] [Full Text] [Related]

  • 19. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.
    J Mol Endocrinol; 2005 Apr 01; 34(2):553-66. PubMed ID: 15821116
    [Abstract] [Full Text] [Related]

  • 20. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P.
    Breast Cancer Res Treat; 2009 May 01; 115(2):349-58. PubMed ID: 18629635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 110.